200 related articles for article (PubMed ID: 18544978)
21. Behavioral and psychological symptoms assessed with the BEHAVE-AD-FW are differentially associated with cognitive dysfunction in Alzheimer's disease.
Ito T; Meguro K; Akanuma K; Meguro M; Lee E; Kasuya M; Ishii H; Mori E
J Clin Neurosci; 2007 Sep; 14(9):850-5. PubMed ID: 17587584
[TBL] [Abstract][Full Text] [Related]
22. Cognitive changes in very old persons with dementia: the influence of demographic, psychometric, and biological variables.
Small BJ; Viitanen M; Winblad B; Bäckman L
J Clin Exp Neuropsychol; 1997 Apr; 19(2):245-60. PubMed ID: 9240484
[TBL] [Abstract][Full Text] [Related]
23. Preference-based quality of life in patients with Alzheimer's disease.
Karlawish JH; Zbrozek A; Kinosian B; Gregory A; Ferguson A; Glick HA
Alzheimers Dement; 2008 May; 4(3):193-202. PubMed ID: 18631968
[TBL] [Abstract][Full Text] [Related]
24. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia.
Savilla K; Kettler L; Galletly C
Aust N Z J Psychiatry; 2008 Jun; 42(6):496-504. PubMed ID: 18465376
[TBL] [Abstract][Full Text] [Related]
25. Quality of Life in healthy old age: relationships with childhood IQ, minor psychological symptoms and optimism.
Bain GH; Lemmon H; Teunisse S; Starr JM; Fox HC; Deary IJ; Whalley LJ
Soc Psychiatry Psychiatr Epidemiol; 2003 Nov; 38(11):632-6. PubMed ID: 14614551
[TBL] [Abstract][Full Text] [Related]
26. Evaluating the quality of life of people with dementia in residential care facilities.
Nakanishi K; Hanihara T; Mutai H; Nakaaki S
Dement Geriatr Cogn Disord; 2011; 32(1):39-44. PubMed ID: 21846987
[TBL] [Abstract][Full Text] [Related]
27. Caregivers' assessments of preference-based quality of life in Alzheimer's disease.
Karlawish JH; Zbrozek A; Kinosian B; Gregory A; Ferguson A; Low DV; Glick HA
Alzheimers Dement; 2008 May; 4(3):203-11. PubMed ID: 18631969
[TBL] [Abstract][Full Text] [Related]
28. [Depression and frontal dysfunction: risks for the elderly?].
Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
[TBL] [Abstract][Full Text] [Related]
29. Effects of Alzheimer's disease and mild cognitive impairment on driving ability: a controlled clinical study by simulated driving test.
Frittelli C; Borghetti D; Iudice G; Bonanni E; Maestri M; Tognoni G; Pasquali L; Iudice A
Int J Geriatr Psychiatry; 2009 Mar; 24(3):232-8. PubMed ID: 18615781
[TBL] [Abstract][Full Text] [Related]
30. CSF biomarkers in relationship to cognitive profiles in Alzheimer disease.
van der Vlies AE; Verwey NA; Bouwman FH; Blankenstein MA; Klein M; Scheltens P; van der Flier WM
Neurology; 2009 Mar; 72(12):1056-61. PubMed ID: 19307538
[TBL] [Abstract][Full Text] [Related]
31. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
[TBL] [Abstract][Full Text] [Related]
32. [Discriminatory validity and association of the mini-mental test (MMSE) and the memory alteration test (M@T) with a neuropsychological battery in patients with amnestic mild cognitive impairment and Alzheimer's disease].
Rami L; Bosch B; Valls-Pedret C; Caprile C; Sánchez-Valle Díaz R; Molinuevo JL
Rev Neurol; 2009 Aug 16-31; 49(4):169-74. PubMed ID: 19621317
[TBL] [Abstract][Full Text] [Related]
33. [Strategy and methods of cognitive rehabilitation in patients with Alzheimer's disease or other dementia].
Jacquemin A
Psychol Neuropsychiatr Vieil; 2009 Dec; 7(4):265-73. PubMed ID: 20031508
[TBL] [Abstract][Full Text] [Related]
34. Rate of cognitive change measured by neuropsychologic test performance in 3 distinct dementia syndromes.
Wicklund AH; Rademaker A; Johnson N; Weitner BB; Weintraub S
Alzheimer Dis Assoc Disord; 2007; 21(4):S70-8. PubMed ID: 18090428
[TBL] [Abstract][Full Text] [Related]
35. Cognitive decline and survival in Alzheimer's disease according to education level.
Bruandet A; Richard F; Bombois S; Maurage CA; Masse I; Amouyel P; Pasquier F
Dement Geriatr Cogn Disord; 2008; 25(1):74-80. PubMed ID: 18042993
[TBL] [Abstract][Full Text] [Related]
36. Reaction to a dementia diagnosis in individuals with Alzheimer's disease and mild cognitive impairment.
Carpenter BD; Xiong C; Porensky EK; Lee MM; Brown PJ; Coats M; Johnson D; Morris JC
J Am Geriatr Soc; 2008 Mar; 56(3):405-12. PubMed ID: 18194228
[TBL] [Abstract][Full Text] [Related]
37. Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study.
Mohs RC; Shiovitz TM; Tariot PN; Porsteinsson AP; Baker KD; Feldman PD
Am J Geriatr Psychiatry; 2009 Sep; 17(9):752-9. PubMed ID: 19700948
[TBL] [Abstract][Full Text] [Related]
38. Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting.
Wattmo C; Hansson O; Wallin AK; Londos E; Minthon L
Dement Geriatr Cogn Disord; 2008; 26(3):203-11. PubMed ID: 18769065
[TBL] [Abstract][Full Text] [Related]
39. Blood pressure, dementia and Alzheimer's disease: the OPTIMA longitudinal study.
Razay G; Williams J; King E; Smith AD; Wilcock G
Dement Geriatr Cogn Disord; 2009; 28(1):70-4. PubMed ID: 19648748
[TBL] [Abstract][Full Text] [Related]
40. How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease?
Benge JF; Balsis S; Geraci L; Massman PJ; Doody RS
Dement Geriatr Cogn Disord; 2009; 28(1):63-9. PubMed ID: 19641319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
